• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

维生素D受体rs2228570多态性与卵巢癌易感性:一项更新的荟萃分析。

Vitamin D receptor rs2228570 polymorphism and susceptibility to ovarian cancer: An updated meta-analysis.

作者信息

Chen Hongmei, Zhu Jin

机构信息

Department of Gynaecology and Obstetrics, Jing'an District Centre Hospital of Shanghai, Shanghai, China.

Department of Gynaecology and Obstetrics, Gynecology Hospital of Fudan University, Shanghai, China.

出版信息

J Obstet Gynaecol Res. 2018 Mar;44(3):556-565. doi: 10.1111/jog.13534. Epub 2017 Dec 14.

DOI:10.1111/jog.13534
PMID:29239065
Abstract

AIM

The FokI polymorphism (C>T, rs2228570) of the vitamin D receptor gene is a coding nonsynonymous single nucleotide polymorphism in the translational initiation codon reported to have functional significance. Although the role of rs2228570 in the risk of ovarian cancer has been widely researched, the association is still unclear. We performed an updated meta-analysis to clarify this issue.

METHODS

Eligible studies were retrieved from electronic databases for the period 2007-2016. The association was measured by unadjusted odds ratio combined with 95% confidence intervals (CIs). Random-effect or fixed-effect models were used according to the heterogeneity of the studies. We further appreciated the strength of evidence according to Venice guidance.

RESULTS

Fourteen studies (4448 cases and 7242 controls) were included in the meta-analysis. Studies were predominantly conducted in Caucasian populations (4152 cases and 6693 controls). A dominant genetic model was determined to be the most appropriate genetic model. Overall meta-analysis showed a fixed-effect odds ratio of 1.14 (95% CI 1.05-1.23) under a dominant model. The fixed-effect odds ratios were 1.12 (95% CI 1.03-1.21) and 1.49 (95% CI 1.06-2.09) in Caucasian and Asian populations, respectively. The strength of the evidence was moderate.

CONCLUSION

The rs2228570 polymorphism increased the risk of ovarian cancer in Caucasian populations in a dominant genetic model. The role of this polymorphism in the risk of ovarian cancer in Asian populations should be further studied.

摘要

目的

维生素D受体基因的FokI多态性(C>T,rs2228570)是翻译起始密码子处的一个编码非同义单核苷酸多态性,据报道具有功能意义。尽管rs2228570在卵巢癌风险中的作用已得到广泛研究,但其关联性仍不明确。我们进行了一项更新的荟萃分析以阐明这一问题。

方法

从2007年至2016年期间的电子数据库中检索符合条件的研究。通过未调整的比值比结合95%置信区间(CIs)来衡量关联性。根据研究的异质性使用随机效应或固定效应模型。我们进一步根据威尼斯指南评估证据的强度。

结果

荟萃分析纳入了14项研究(4448例病例和7242例对照)。研究主要在白种人群中进行(4152例病例和6693例对照)。确定显性遗传模型为最合适的遗传模型。总体荟萃分析显示,在显性模型下,固定效应比值比为1.14(95%CI 1.05 - 1.23)。在白种人和亚洲人群中,固定效应比值比分别为1.12(95%CI 1.03 - 1.21)和1.49(95%CI 1.06 - 2.09)。证据强度为中等。

结论

在显性遗传模型中,rs2228570多态性增加了白种人群患卵巢癌的风险。该多态性在亚洲人群卵巢癌风险中的作用应进一步研究。

相似文献

1
Vitamin D receptor rs2228570 polymorphism and susceptibility to ovarian cancer: An updated meta-analysis.维生素D受体rs2228570多态性与卵巢癌易感性:一项更新的荟萃分析。
J Obstet Gynaecol Res. 2018 Mar;44(3):556-565. doi: 10.1111/jog.13534. Epub 2017 Dec 14.
2
Vitamin D receptor rs2228570 polymorphism and susceptibly to ovarian cancer: a meta-analysis.维生素D受体rs2228570多态性与卵巢癌易感性:一项荟萃分析
Tumour Biol. 2014 Feb;35(2):1319-22. doi: 10.1007/s13277-013-1175-3. Epub 2013 Oct 18.
3
Vitamin D receptor rs2228570 polymorphism and invasive ovarian carcinoma risk: pooled analysis in five studies within the Ovarian Cancer Association Consortium.维生素 D 受体 rs2228570 多态性与侵袭性卵巢癌风险:卵巢癌协会联盟内五个研究的合并分析。
Int J Cancer. 2011 Feb 15;128(4):936-43. doi: 10.1002/ijc.25403.
4
The VDR gene FokI polymorphism and ovarian cancer risk.维生素D受体(VDR)基因FokI多态性与卵巢癌风险
Tumour Biol. 2013 Dec;34(6):3309-16. doi: 10.1007/s13277-013-0826-8.
5
Association of vitamin D receptor gene variants with polycystic ovary syndrome: a meta-analysis.维生素 D 受体基因变异与多囊卵巢综合征的关联:荟萃分析。
BMC Med Genet. 2019 Feb 14;20(1):32. doi: 10.1186/s12881-019-0763-5.
6
Do genetic polymorphisms of the vitamin D receptor contribute to breast/ovarian cancer? A systematic review and network meta-analysis.维生素 D 受体的遗传多态性是否与乳腺癌/卵巢癌有关?系统评价和网络荟萃分析。
Gene. 2018 Nov 30;677:211-227. doi: 10.1016/j.gene.2018.07.070. Epub 2018 Jul 29.
7
Association of the vitamin D receptor FokI gene polymorphism with sex- and non-sex-associated cancers: A meta-analysis.维生素D受体FokI基因多态性与性别相关和非性别相关癌症的关联:一项荟萃分析。
Tumour Biol. 2017 Oct;39(10):1010428317727164. doi: 10.1177/1010428317727164.
8
Meta-analysis of the relation between vitamin D receptor gene BsmI polymorphism and susceptibility to ovarian cancer.维生素D受体基因BsmI多态性与卵巢癌易感性关系的Meta分析。
Tumour Biol. 2013 Dec;34(6):3317-21. doi: 10.1007/s13277-013-0900-2. Epub 2013 Jun 20.
9
Vitamin D receptor rs2228570 polymorphism and Parkinson's disease risk in a Chinese population.维生素D受体rs2228570多态性与中国人群帕金森病风险
Neurosci Lett. 2020 Jan 19;717:134722. doi: 10.1016/j.neulet.2019.134722. Epub 2019 Dec 23.
10
Vitamin D Receptor Gene Polymorphisms and the Risk of Metabolic Syndrome (MetS): A Meta-Analysis.维生素D受体基因多态性与代谢综合征(MetS)风险:一项荟萃分析
Endocr Metab Immune Disord Drug Targets. 2021;21(5):943-955. doi: 10.2174/1871530320666200805101302.

引用本文的文献

1
Vitamin D in Cancer Prevention and Treatment: A Review of Epidemiological, Preclinical, and Cellular Studies.维生素D在癌症预防与治疗中的作用:流行病学、临床前及细胞研究综述
Cancers (Basel). 2024 Sep 20;16(18):3211. doi: 10.3390/cancers16183211.
2
Vitamin D/vitamin D receptor, autophagy, and infection.维生素 D/维生素 D 受体、自噬和感染。
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2022 Jun 28;47(6):780-785. doi: 10.11817/j.issn.1672-7347.2022.210556.
3
The association between single nucleotide polymorphisms and ovarian cancer risk: A systematic review and network meta-analysis.
单核苷酸多态性与卵巢癌风险的关联:系统评价和网络荟萃分析。
Cancer Med. 2023 Jan;12(1):541-556. doi: 10.1002/cam4.4891. Epub 2022 May 30.
4
Levels of 25-hydroxy Vitamin D3 and Vitamin D Receptor Polymorphism in Severe Dengue Cases from New Delhi.新德里重症登革热病例中25-羟基维生素D3水平及维生素D受体多态性
Trop Med Infect Dis. 2020 May 3;5(2):72. doi: 10.3390/tropicalmed5020072.
5
Association about dietary vitamin C intake on the risk of ovarian cancer: a meta-analysis.膳食维生素 C 摄入与卵巢癌风险的关联:一项荟萃分析。
Biosci Rep. 2020 Aug 28;40(8). doi: 10.1042/BSR20192385.
6
Strong association between VDR FokI (rs2228570) gene variant and serum vitamin D levels in Turkish Cypriots.土耳其塞浦路斯人维生素 D 受体 FokI(rs2228570) 基因变异与血清维生素 D 水平之间存在很强的关联性。
Mol Biol Rep. 2019 Jun;46(3):3349-3355. doi: 10.1007/s11033-019-04796-6. Epub 2019 Apr 12.
7
Repurposing vitamin D for treatment of human malignancies targeting tumor microenvironment.将维生素D重新用于治疗针对肿瘤微环境的人类恶性肿瘤。
Acta Pharm Sin B. 2019 Mar;9(2):203-219. doi: 10.1016/j.apsb.2018.09.002. Epub 2018 Sep 6.
8
Influence of vitamin D on cancer risk and treatment: Why the variability?维生素D对癌症风险和治疗的影响:为何存在差异?
Trends Cancer Res. 2018;13:43-53.